Proteon Pharmaceuticals
PrivateLast Round
Grant
Nov 9, 2022
Total Funding Raised
$33.91M
Company Overview
Proteon Pharmaceuticals operates in Healthcare & Life Sciences and is based in Poland. Its latest recorded funding round was a Grant round in November 2022.
Proteon Pharmaceuticals is a biotechnology company that develops bacteriophage-based products to reduce the need for antibiotics in livestock farming and aquaculture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proteon Pharmaceuticals Comparables
Compare Proteon Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhageLab | 88% | |
| Phagos | 85% | |
| NexaBiome | 84% |
For institutional investors. Book with your work email.
Proteon Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 9, 2022 | ||||
| Series B | Aug 10, 2021 | ||||
| Series A | Oct 26, 2017 | ||||
| Grant | Feb 6, 2017 | ||||
| Grant | Sep 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Proteon Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newtree Impact | Series B |
| Calouste Gulbenkian Foundation | Grant |
| Bluebio Alliance | Grant |
| PFR Life Science | Series B |
| Aqua-Spark | Series B, Series A |
| maze impact | Grant |
| Oceano Azul Foundation | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2022
$45K grant round led by Blue Bio Value.
- Aug 10, 2021
$25M round led by Aqua-Spark and Nutreco.
For institutional investors. Book with your work email.
Proteon Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proteon Pharmaceuticals's valuation, stock price, and market status.
Is Proteon Pharmaceuticals a public or private company?
Proteon Pharmaceuticals is a private company.
What is the current stock price of Proteon Pharmaceuticals?
Proteon Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Proteon Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proteon Pharmaceuticals worth (valuation)?
Valuation information for Proteon Pharmaceuticals is not publicly available.
Can I buy Proteon Pharmaceuticals stock?
Proteon Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proteon Pharmaceuticals's last funding round?
Proteon Pharmaceuticals's most recent funding round was Grant on November 9, 2022.
Who are the main investors in Proteon Pharmaceuticals?
Key investors in Proteon Pharmaceuticals include PFR Life Science, Aqua-Spark, Blue Bio Value.
Will Proteon Pharmaceuticals IPO soon?
No public IPO plans have been announced for Proteon Pharmaceuticals.
How can I track Proteon Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Proteon Pharmaceuticals's shares on secondary markets.